… of antidepressants on the overall survival of the studied cohort of lung cancer patients [129]. …
TCAs translated to improved survival in patients with colorectal cancer or glioma showed no …

… prevention of both colorectal cancer and glioma. The same group of authors in a following
paper [73] assessed the survival of CRC patients who used TCAs post-diagnosis: the authors …

… with shorter survival in patients with gliomas, and patients with gliomas with … antidepressant
use on the risk of glioma [85,86]. Tricyclic antidepressants (TCAs) reduce the risk of glioma …

… patients with either colorectal cancer or glioma, there was no significant mortality reduction
in those who used tricyclic antidepressants (… with increased survival in patients with cancer, …

… survival rate of colorectal liver metastases patients after surgical resection is up to 50%, but
only 20% of patients … inhibitor (SNRI) and tricyclic antidepressant (TCA) treat depression. The …

… of using tricyclic antidepressants for mortality reduction in people with glioma or colorectal
cancer. … , examining the relationship between depression and survival in glioma. However, the …

… in colorectal carcinoma, glioblastoma and breast cancer cell … restricted to colorectal cancer
and breast cancer and caused … tumors are highly dependent on autophagy for survival and …

… survival for glioblastoma patients well enough to receive the standard of care treatment is just
14.6 months post-diagnosis … Clomipramine is a tricyclic antidepressant drug that is effective …

… , 2 publications included serotonin and norepinephrine reuptake inhibitors (SNRIs), 5
publications included tricyclic antidepressants (TCAs), and 7 publications included other atypical …

… worsen overall survival and prognosis in patients with brain … inhibitors (SSRIs), the tricyclic
antidepressants (TCA) and the … of using TCAs for patients with glioma or colorectal cancer. …